ENTA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Enanta Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 12 USD 3.09%

Market Cap: $349m

	Enanta Pharmaceuticals Inc NASDAQ:ENTA	US
Q	QRT Inc KOSDAQ:405100	KR
	WD-40 Co NASDAQ:WDFC	US
	Nordic Semiconductor ASA F:N0S	NO

Profitability Summary

Enanta Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-90%

Negative 3Y Average Operating Margin

-147%

Operating Margin is Increasing

-173% > -90%

Negative Net Margin

-97%

Negative 3Y Average Net Margin

-143%

Net Margin is Increasing

-169% > -97%

Negative Free Cash Flow Margin

-57%

Negative 3Y Average Free Cash Flow Margin

-96%

Free Cash Flow Margin is Increasing

-142% > -57%

Negative ROE

-70%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-89%

ROIC is Increasing

-134% > -60%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.